63
Views
0
CrossRef citations to date
0
Altmetric
Cancer Pain and Palliative Care

Current Status of Cognition and Clinical Practice of Refractory Cancer Pain in Shanghai: A Questionnaire Survey

ORCID Icon, , , , , , , , , , , , ORCID Icon, & show all
Pages 1413-1422 | Received 19 Dec 2023, Accepted 04 Apr 2024, Published online: 09 Apr 2024

References

  • Wild CP, Weiderpass E, Stewart BW. World cancer report: cancer research for cancer prevention. Lyon, France: International Agency for Research on Cancer; 2020. Available from: https://publications.iarc.fr/586. Accessed April 05, 2024.
  • Currow DC, Spruyt O, Hardy J. Defining refractory pain in cancer for clinicians and researchers. J Palliat Med. 2012;15(1):5–6. doi:10.1089/jpm.2011.0326
  • Hardy J, Quinn S, Fazekas B, et al. Double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol. 2012;30(29):3611–3617. doi:10.1200/JCO.2012.42.1081
  • Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence, and characteristics. Pain. 1990;41(3):273–281. doi:10.1016/0304-3959(90)90004-W
  • Deandrea S, Corli O, Consonni D, Villani W, Greco MT, Apolone G. Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manage. 2014;47(2):57–76. doi:10.1016/j.jpainsymman.2013.02.015
  • Davies AN, Elsner F, Filbet MJ, et al. Breakthrough cancer pain (BTcP) management: a review of international and national guidelines. BMJ Support Palliat Care. 2018;8(3):241–249. doi:10.1136/bmjspcare-2017-001467
  • World Health Organization. WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. Geneva: World Health Organization; 2018.
  • Fallon M, Giusti R, Aielli F, et al. Management of cancer pain in adult patients: ESMO clinical practice guidelines. Ann Oncol. 2018;29(Suppl 4):iv166–iv191. doi:10.1093/annonc/mdy152
  • George B, Minello C, Allano G, Maindet C, Burnod A, Lemaire A. Opioids in cancer-related pain: current situation and outlook. Support Care Cancer. 2019;27(3):3105–3118. doi:10.1007/s00520-019-04828-8
  • Nijland L, Schmidt P, Frosch M, et al. Subcutaneous or intravenous opioid administration by patient-controlled analgesia in cancer pain: a systematic literature review. Support Care Cancer. 2019;27(1):33–42. doi:10.1007/s00520-018-4368-x
  • Fainsinger RL, Nekolaichuk CL. A “TNM” classification system for cancer pain: the Edmonton Classification System for Cancer Pain (ECS-CP). Support Care Cancer. 2008;16(6):547–555. doi:10.1007/s00520-008-0423-3
  • Yu S, Wang XS, Cheng Y, Yang J, Cleeland CS. Special aspects of cancer pain management in a Chinese general hospital. Eur J Pain. 2001;5(Suppl A):15–20. doi:10.1053/eujp.2001.0274
  • Breuer B, Fleishman SB, Cruciani RA, Portenoy RK. Medical oncologists’ attitudes and practice in cancer pain management: a national survey. J Clin Oncol. 2011;29(36):4769–4775. doi:10.1200/JCO.2011.35.0561